The adoption follows the successful completion of a pivotal research study conducted at the Baltimore VA that demonstrated the clinical potential of GaitBetter. We are proud to adopt GaitBetter at the ...
NEW YORK CITY, NEW YORK / ACCESS Newswire / January 30, 2026 / Virtuix Holdings, Inc. (NASDAQ:VTIX), a leader in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results